Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Curevo is a clinical-stage biotechnology company developing next-generation, non-mRNA vaccines for infectious diseases.
Genetix Biotherapeutics develops and delivers approved gene therapies for severe rare genetic diseases like sickle cell.
Atalanta Therapeutics is a biotechnology company pioneering new treatment options for neurodegenerative diseases.
Nura Bio is a clinical-stage biopharmaceutical company focused on developing neuroprotective therapies to treat neurological diseases.
Atropos Health develops a clinical analytics platform that specializes in evidence-based healthcare.
Nucleai is a spatial biology company that has developed an AI-powered platform to enhance drug development and improve patient outcomes.
NextPoint Therapeutics is a clinical-stage biotechnology company that develops therapeutics to treat cancer patients.
Sudo Biosciences is a biopharma company that designs and develops medicines that target the tyrosine kinase 2 (TYK2) pseudokinase domain.
ROME Therapeutics is developing novel therapies for cancer and autoimmune diseases by harnessing the power of the repeatome.
Tisento Therapeutics is a MA-based developer of novel medicines to treat diseases with significant unmet medical needs.
Inozyme is a biopharmaceutical company developing therapeutics for rare diseases, with a focus on bone health.
Veralox Therapeutics develops small molecule therapeutics that treat the underlying pathologies of thrombosis and type one diabetes.
OMass Therapeutics is a drug discovery company exploiting novel mass spectrometry platforms to develop therapeutics.
QurAlis is a biotechnology company that creates precision medicine solutions to cure ALS and FTD.
Avilar Therapeutics is a biopharmaceutical company focusing on extracellular protein degradation.
Matchpoint Therapeutics is a biotechnology company that integrates chemoproteomics, ML, and covalent chemistry to treat serious illnesses.
Empatica is an affective computing company focused on human data analytics.
Common Sensing develops and manufactures data-driven hardware and software solutions for people using injectable medicine.
Lava Therapeutics is a developer of a bispecific antibody platform used to engage gamma-delta T cells for the treatment of cancer.
NodThera is a biotechnology company focused on the discovery and development of new treatments for diseases.
Innovative Healthcare Contracting
NeuroVia is a biopharmaceutical company.
Lysosomal Therapeutics deliver cures for neurodegenerative diseases.
Lumena Pharmaceuticals develops oral therapeutics for rare liver diseases to improve liver function and relieve disease symptoms.
Sanofi Ventures has invested in 72 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Sanofi Ventures's top investment sectors include Biotechnology, Health Care, Medical, Pharmaceutical, Therapeutics. The firm invests across 21 different industry categories.
Among tracked funding rounds, Curevo received $110.0M in a Series B round. Sanofi Ventures's total known invested capital is $4.1B.
Sanofi Ventures's average investment size is $59.7M across its portfolio of 72 companies.
Recent Sanofi Ventures portfolio additions include Curevo, Genetix Biotherapeutics Inc., Atalanta Therapeutics, Nura Bio, Atropos Health. These companies were founded in 2020 or later.